Shandong Xinhua Pharmaceutical Company Limited (HKG:0719)

HKG:0719 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,275	1,245	918.33	1,159	744.66	855.77
Cash & Short-Term Investments	1,275	1,245	918.33	1,159	744.66	855.77
Cash Growth	27.97%	35.57%	-20.75%	55.61%	-12.98%	23.94%
Accounts Receivable	1,378	1,120	949.16	970.63	870.46	518.55
Other Receivables	17.94	9.5	9.34	12.65	17.42	25.16
Receivables	1,396	1,129	958.5	983.28	887.87	543.71
Inventory	1,229	1,273	1,313	1,212	1,028	1,124
Prepaid Expenses	0.02	0.03	3.41	-	-	7.15
Other Current Assets	92.41	79.78	121.1	102.95	93.88	155.88
Total Current Assets	3,992	3,727	3,314	3,457	2,754	2,687
Property, Plant & Equipment	4,242	4,296	4,061	4,000	3,766	3,539
Long-Term Investments	322.9	306.42	241.37	239.18	260.2	316.62
Other Intangible Assets	542.57	565.04	494.94	474.11	466.45	449.25
Long-Term Deferred Tax Assets	18.28	24.92	23.48	15.62	15.17	23.52
Long-Term Deferred Charges	14.77	9.99	14.46	8.61	10.54	11.92
Other Long-Term Assets	105.53	90.75	136.77	69.85	59.99	65.93
Total Assets	9,238	9,020	8,286	8,265	7,332	7,093
Accounts Payable	1,321	1,159	1,178	1,090	1,066	742.9
Accrued Expenses	500.67	137.28	203.11	159.43	122.35	144.87
Short-Term Debt	252.93	580.16	283.96	118.02	269.46	200.42
Current Portion of Long-Term Debt	704.97	312.26	271.97	714.77	421.03	356.55
Current Portion of Leases	1.35	1.4	1.78	2.69	2.8	1.56
Current Income Taxes Payable	11.79	6.69	5.03	7.99	12.2	4.42
Current Unearned Revenue	59.78	96.84	149.14	593.26	100.4	377.79
Other Current Liabilities	299.61	502.3	393.16	472.23	507.26	552.53
Total Current Liabilities	3,152	2,796	2,486	3,158	2,502	2,381
Long-Term Debt	490.32	771.54	799.4	545.66	946.2	1,063
Long-Term Leases	1.43	1.11	1.58	2.72	6.77	23.93
Long-Term Unearned Revenue	77.76	83.25	100.67	118.37	133.97	146.5
Long-Term Deferred Tax Liabilities	123.9	122.53	99.21	66.44	65.61	69.31
Other Long-Term Liabilities	27.06	28.06	23.56	23.56	26.46	18.14
Total Liabilities	3,873	3,802	3,510	3,915	3,681	3,702
Common Stock	689.78	682.41	674.68	669.63	627.37	621.86
Additional Paid-In Capital	1,200	1,145	1,055	998.14	677.94	644.91
Retained Earnings	3,040	2,989	2,706	2,345	2,034	1,780
Comprehensive Income & Other	197.13	175.86	117.01	113.68	128.37	177.21
Total Common Equity	5,127	4,992	4,553	4,126	3,468	3,224
Minority Interest	238.25	225.91	222.65	223.29	183.2	167.5
Shareholders' Equity	5,365	5,218	4,776	4,350	3,651	3,391
Total Liabilities & Equity	9,238	9,020	8,286	8,265	7,332	7,093
Total Debt	1,451	1,666	1,359	1,384	1,646	1,645
Net Cash (Debt)	-175.98	-421.45	-440.36	-225.11	-901.58	-789.42
Net Cash Per Share	-0.26	-0.61	-0.64	-0.34	-1.44	-1.26
Filing Date Shares Outstanding	689.78	689.78	682.41	669.63	627.37	627.37
Total Common Shares Outstanding	689.78	682.41	674.68	669.63	627.37	621.86
Working Capital	839.89	931.23	828.33	298.47	252.08	305.83
Book Value Per Share	7.43	7.31	6.75	6.16	5.53	5.18
Tangible Book Value	4,584	4,427	4,058	3,652	3,001	2,775
Tangible Book Value Per Share	6.65	6.49	6.01	5.45	4.78	4.46
Buildings	2,557	2,411	2,271	2,244	2,078	1,948
Machinery	5,248	5,128	4,703	4,468	4,011	3,690
Construction In Progress	695.99	781.1	730.55	545.89	562.96	416.99

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.